2nd Edition of Inscitech Meet on
Advanced Pulmonology, Respiratory Medicine & Lung Health
IMPULMONO2027
Rome, Italy July 05-07, 2027
Early Bird Registration December 10, 2026
About Conference
2nd Edition of Inscitech Meet on Advanced Pulmonology, Respiratory Medicine & Lung Health
The 2nd Edition of InSciTech Meet on Advanced
Pulmonology, Respiratory Medicine & Lung Health (IMPULMONO2027)
will take place from July
05–07, 2027, in Rome, Italy. This international scientific
conference will bring together pulmonologists,
respiratory physicians, researchers, academicians, clinicians, thoracic
specialists, healthcare professionals, scientists, and industry experts
to discuss the latest advances, emerging therapies, innovative technologies,
and transformative approaches in pulmonology, respiratory medicine, and lung
health.
Organized
by InSciTech Summits,
the three-day event will feature keynote
presentations, invited talks, scientific sessions, oral and poster
presentations, interactive workshops designed to encourage
interdisciplinary collaboration, exchange clinical and scientific knowledge,
and accelerate the development and application of innovative approaches to
respiratory healthcare.
The
global pulmonary and
respiratory healthcare market is projected to experience substantial growth
through 2030, driven by the increasing prevalence of
respiratory diseases, technological advancements in diagnostics and treatment,
growing healthcare expenditure, and rising demand for personalized and
preventive respiratory care.
Market
segments include pulmonology,
respiratory medicine, critical care, pulmonary infections, COPD and asthma,
interstitial lung diseases, pulmonary hypertension. Key
application areas include early
diagnosis, precision medicine, drug development, minimally invasive procedures,
AI-assisted diagnostics, remote patient monitoring, respiratory devices,
clinical research, rehabilitation, and advanced patient-care technologies.
Important Dates
Conference Updates
- Conference Dates July 05-07, 2027
- Early Bird Registration December 10, 2026
- Abstract Submission Deadline December 05, 2026
- Conference Venue Rome, Italy
Collaborations and Event Updates
Plenary Speakers
Dr. Konstantinos Syrigos
National and Kapodistrian University of Athens
Greece
Dr. Konstantinos Syrigos
National and Kapodistrian University of AthensGreece
Biography
Professor Kostas Syrigos graduated from the Athens School of
Medicine in 1988. He completed his training in Internal Medicine
at Laikon University Hospital (Athens School of Medicine,
National and Kapodistrian University of Athens – NKUA), and
subsequently specialized in Medical Oncology at Hammersmith
Hospital (Imperial College of Medicine, Science and Art,
University of London).
He received his MD with distinction from the Athens School of
Medicine in 1995, and earned a PhD in Immuno-Oncology from Imperial College London
in 2000. His clinical career includes positions as Senior Registrar in Medical Oncology
at both Hammersmith and St Bartholomew’s Hospitals in London, as well as Consultant
in the 3rd Department of Medicine at the ‘Sotiria’ General Hospital in Athens.
In 2002, he was appointed Associate Professor of Oncology in Medicine and became
Head of the Sotiria Oncology Unit. Since 2008, he has served as Visiting Professor of
Thoracic Oncology at Yale School of Medicine, Yale Cancer Center, and Smilow Cancer
Hospital (CT, USA), and since 2012 as Adjunct Professor of Medicine at the University
of Pittsburgh School of Medicine (USA).
Since 2014, Professor Syrigos has led the 3rd Department of Medicine and Oncology
Unit at the Athens School of Medicine, NKUA, based at ‘Sotiria’ General Hospital. In
2019, he was appointed Chair of the Faculty of Medicine at the Athens Medical School,
NKUA.
He is the Director and Scientific Chair of two postgraduate programs leading to a
Master's degree:
New Drug Development: Research, Approval & Access
Thoracic Oncology: Current Clinical & Laboratory Approach and Research
His primary research interests include clinical oncology, drug development, immuno-
oncology, and thoracic as well as head & neck cancers. He has participated in more
than 200 international Phase I–IV clinical trials involving lung, head and neck, colorectal,
breast, and pancreatic cancers. He has served as a Global Principal Investigator and
member of numerous Scientific Steering Committees for international trials.
Professor Syrigos is an active member of several leading scientific societies, including
the American Society of Clinical Oncology (ASCO), American Association for Cancer
Research (AACR), American College of Chest Physicians (ACCP), European Society
of Medical Oncology (ESMO), European Respiratory Society (ERS), and the
International Association for the Study of Lung Cancer (IASLC).
Speech Title
Dr. Fiammetta Danzo
Respiratory Physician at Policlinico di Milano
Italy
Dr. Fiammetta Danzo
Respiratory Physician at Policlinico di MilanoItaly
Biography
Dr. Fiammetta Danzo is a Consultant Respiratory Physician at Policlinico di Milano, Italy, where she is one of the responsible of the Interstitial Lung Disease and Rare Lung Disease Outpatient Clinic. She is also a PhD candidate in Clinical Research at the University of Milan. She previously gained research experience at the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, UK, within the Scleroderma Research Group, and subsequently undertook a clinical research fellowship at the Interstitial Lung Disease Unit of the Royal Brompton Hospital in London. Her clinical and research interests focus on interstitial lung diseases, particularly connective tissue disease-associated ILDs and pulmonary fibrosis, with a special interest in emerging therapeutic strategies and innovative approaches to disease monitoring and progression assessment
Speech Title
Connective Tissue Disease-Associated Interstitial Lung Diseases (CTD-ILD): from early detection to personalised management
Dr. James Awotoye
Senior Laboratory Scientist & Public Health Specialist
Nigeria
Dr. James Awotoye
Senior Laboratory Scientist & Public Health SpecialistNigeria
Biography
James Awotoye is a Senior Laboratory Scientist and Public Health Specialist with over 13 years of experience in laboratory diagnostics, infectious disease control, and public health programme implementation in Nigeria. His expertise includes tuberculosis (TB) and drug-resistant TB diagnostics, molecular testing, laboratory quality management, and strengthening diagnostic networks to improve access to timely and reliable healthcare services.
He has extensive experience providing technical assistance to tuberculosis reference laboratories, strengthening specimen referral networks, supporting molecular diagnostic services, and building laboratory capacity across Nigeria. His work focuses on improving diagnostic accuracy, reducing turnaround times, and expanding access to quality-assured testing, particularly in resource-limited settings.
His professional interests include pulmonary infections, innovative molecular diagnostics, laboratory systems strengthening, and improving access to timely, quality-assured diagnostic services to support better respiratory health outcomes.
Speech Title
Dr. Alvar Agusti
University of Barcelona
Spain
Dr. Alvar Agusti
University of BarcelonaSpain
Biography
Speech Title
Dr. Richard Nho
Ohio State University Collage of Medicine
Dr. Richard Nho
Ohio State University Collage of MedicineBiography
My research seeks to uncover how idiopathic pulmonary fibrosis (IPF) fibroblasts maintain an apoptosis-resistant, pathological phenotype within a collagen-rich extracellular matrix (ECM) and to develop strategies to selectively target fibrotic fibroblast subtypes to halt disease progression. IPF, the most common and lethal idiopathic interstitial lung disease, is marked by fibroblast accumulation and deposition of a stiff, collagen-dense ECM. Existing therapies cannot reverse established fibrosis, leaving a critical unmet clinical need.
Using precision-cut lung slices, 3D collagen matrices, and patient-derived decellularized ECMs, we model the fibrotic lung microenvironment under clinically relevant pro-fibrotic conditions, including hypoxia. Our studies identified lactate-mediated signaling via GPR81 as a key driver of fibroblast reprogramming and revealed aberrant upregulation of the transcription factor ZEB1, a regulator of ECM stiffness and apoptosis resistance in IPF fibroblasts, patient tissues, and fibrotic mouse lungs. Importantly, targeting lactate shuttling and ZEB1 significantly reduces lung fibrosis in vivo.
These findings establish a foundation for fibroblast subtype-targeted therapies, including antimiRs, in vivo neutralizing antibodies, and Cy5.5-labeled biodegradable nanoparticles for targeted drug delivery. This work paves the way for mechanistically informed interventions to halt fibrosis and improve outcomes for patients with IPF.
Speech Title
Keynote Speakers
Dr. Sithabiso Dube
Union Zimbabwe Trust
Zimbabwe
Dr. Sithabiso Dube
Union Zimbabwe TrustZimbabwe
Biography
Speech Title
Dr. Steven Batur
KNCV Tuberculosis Foundation
Nigeria
Dr. Steven Batur
KNCV Tuberculosis FoundationNigeria
Biography
Speech Title
Dr. Ongbabo Joseph Alade
KNCV Tuberculosis Foundation
Nigeria
Dr. Ongbabo Joseph Alade
KNCV Tuberculosis FoundationNigeria
Biography
Speech Title
Invited Speakers
Dr. Jacopo Saccomanno
Charite – University Medicine
Berlin
Dr. Jacopo Saccomanno
Charite – University MedicineBerlin
Biography
Speech Title
Dr. Bailee W. Olliff
University of Colorado School of Medicine
USA
Dr. Bailee W. Olliff
University of Colorado School of MedicineUSA
Biography
Dr. Bailee Williams Olliff is a dual board-certified trauma and acute care surgeon specializing in General Surgery and Surgical Critical Care. She currently serves as the Trauma Medical Director at Denver Health, a major academic Level I Trauma Center in Denver, Colorado, and as an Assistant Professor of Surgery at the University of Colorado School of Medicine.
Dr. Olliff completed her General Surgery residency at the University of South Florida, followed by fellowship training in Surgical Critical Care at Brown University/Rhode Island Hospital.
Her clinical interests include thoracic and pulmonary trauma, surgical stabilization of rib fractures, video-assisted thoracoscopic surgery (VATS), management of complex hemothoraces, and the resuscitation of critically injured patients.
In addition to her clinical practice, Dr. Olliff is actively involved in trauma system leadership, quality improvement, and surgical education. She serves as a Trauma Surgeon Reviewer for the Colorado Department of Public Health and Environment and holds a leadership position on Colorado's State Trauma Advisory Committee.
A dedicated educator and invited speaker, Dr. Olliff is passionate about advancing evidence-based trauma care, multidisciplinary collaboration, and education across the continuum of emergency and critical care.
Speech Title
Dr. Saibe Fulya Elmastas Akkus
University of Health Sciences
Turkey
Dr. Saibe Fulya Elmastas Akkus
University of Health SciencesTurkey
Biography
Speech Title
Scientific Sessions
- Advanced Clinical Pulmonology & Respiratory Care
- Asthma & Severe Airway Disease
- Interstitial Lung Diseases & Pulmonary Fibrosis
- Interventional Pulmonology & Bronchoscopy
- Mechanical Ventilation & Respiratory Support
- Geriatric Respiratory Medicine
- Lung Microbiome & Host–Pathogen Interactions
- Occupational Lung Diseases & Workplace Respiratory Health
- Advanced Respiratory Imaging, Diagnostics & Biomarkers
- Respiratory Pharmacology, Biologics & Novel Therapeutics
- Rare & Genetic Pulmonary Diseases
- Digital Health, AI & Remote Respiratory Monitoring
- COPD: Emerging Therapies & Disease Management
- Bronchiectasis & Chronic Airway Disorders
- Pulmonary Hypertension & Vascular Lung Disorders
- Thoracic Oncology & Lung Cancer
- Critical Care, ARDS & Acute Respiratory Failure
- Sleep Medicine & Sleep-Disordered Breathing
- Pediatric Pulmonology & Childhood Lung Diseases
- Pulmonary Infections, Tuberculosis & Emerging Pathogens
- Environmental Pollution & Lung Health
- Smoking, Vaping & Tobacco-Related Lung Disease
- Precision Pulmonology & Personalized Respiratory Medicine
- Lung Transplantation & Advanced Lung Therapies
- Autoimmune, Inflammatory & Vasculitic Lung Diseases
- Regenerative Medicine, Gene Therapy & Lung Repair
